Chapman, R.; van Diepen, M.; Galant, S.; Kruse, E.; Margolin, E.; Ximba, P.; Hermanus, T.; Moore, P.; Douglass, N.; Williamson, A.-L.;
et al. Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles. Vaccines 2020, 8, 54.
https://doi.org/10.3390/vaccines8010054
AMA Style
Chapman R, van Diepen M, Galant S, Kruse E, Margolin E, Ximba P, Hermanus T, Moore P, Douglass N, Williamson A-L,
et al. Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles. Vaccines. 2020; 8(1):54.
https://doi.org/10.3390/vaccines8010054
Chicago/Turabian Style
Chapman, Rosamund, Michiel van Diepen, Shireen Galant, Elizabeth Kruse, Emmanuel Margolin, Phindile Ximba, Tandile Hermanus, Penny Moore, Nicola Douglass, Anna-Lise Williamson,
and et al. 2020. "Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles" Vaccines 8, no. 1: 54.
https://doi.org/10.3390/vaccines8010054
APA Style
Chapman, R., van Diepen, M., Galant, S., Kruse, E., Margolin, E., Ximba, P., Hermanus, T., Moore, P., Douglass, N., Williamson, A.-L., & Rybicki, E.
(2020). Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles. Vaccines, 8(1), 54.
https://doi.org/10.3390/vaccines8010054